デフォルト表紙
市場調査レポート
商品コード
1085539

呼吸器疾患検査の世界市場:検査タイプ別、エンドユーザー別、地域別-規模、シェア、展望、機会分析(2022年~2028年)

Respiratory Disease Testing Market, By Test Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 155 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
呼吸器疾患検査の世界市場:検査タイプ別、エンドユーザー別、地域別-規模、シェア、展望、機会分析(2022年~2028年)
出版日: 2022年05月04日
発行: Coherent Market Insights
ページ情報: 英文 155 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

呼吸器疾患検査製品の認可の増加、先進国および発展途上国における呼吸器疾患の有病率の増加、製品開発における技術的進歩の増加は、呼吸器疾患検査市場の成長を促進すると予想されます。

当レポートでは、世界の呼吸器疾患検査市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場の内訳:検査タイプ別
    • 市場の内訳:エンドユーザー別
    • 市場の内訳:国別
    • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主なハイライト
  • 製品発売
  • PEST分析
  • 技術の進歩
  • 規制シナリオ
  • 合併と買収
  • COVID-19の市場への影響

第4章 世界の呼吸器疾患検査市場:検査タイプ別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 画像検査
  • スパイロメトリー
  • ピークフローテスト
  • 血液ガス検査
  • 肺気量検査
  • その他

第5章 世界の呼吸器疾患検査市場:エンドユーザー別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 病院
  • 診療所
  • 臨床研究所

第6章 世界の呼吸器疾患検査市場:地域別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第7章 競合情勢

  • 企業プロファイル
    • CareFusion Corporation
    • Carestream Health, Inc.
    • COSMED
    • Futuremed America, Inc.
    • GE Healthcare
    • MGC Diagnostics Corporation
    • ndd Medical Technologies, Inc.
    • Nihon Kohden Corporation
    • PerkinElmer, Inc.
    • Philips Healthcare
    • Quest Diagnostics

第8章 セクション

目次
Product Code: CMI4030

The respiratory system is divided into two parts; upper respiratory tract and lower respiratory tract. The upper respiratory tract includes pharynx, larynx and nasal passages, while the lower respiratory tract includes trachea, lungs and bronchi. Respiratory Disease Testing is carried out for diagnosis of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and pneumonia. Increasing product approvals, increasing prevalence of respiratory disorders in developed and developing economies along with increasing technological advancements in product development.

Key features of the study:

  • This report provides in-depth analysis of the Global Respiratory Disease Testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Respiratory Disease Testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., Philips Healthcare, and Quest Diagnostics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Respiratory Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Respiratory Disease Testing market

Detailed Segmentation:

  • Global Respiratory Disease Testing Market, By Test Type:
    • Imaging Test
    • Spirometry
    • Peak Flow Test
    • Blood Gas Test
    • Lung Volume Test
    • Others
  • Global Respiratory Disease Testing Market, By End User:
    • Hospitals
    • Physician Offices
    • Clinical Laboratories
  • Global Respiratory Disease Testing Market, By Region:
    • North America
      • By Test Type:
      • Imaging Test
      • Spirometry
      • Peak Flow Test
      • Blood Gas Test
      • Lung Volume Test
      • Others
      • By End User
      • Hospitals
      • Physician Offices
      • Clinical Laboratories
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Test Type:
      • Imaging Test
      • Spirometry
      • Peak Flow Test
      • Blood Gas Test
      • Lung Volume Test
      • Others
      • By End User
      • Hospitals
      • Physician Offices
      • Clinical Laboratories
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Test Type:
      • Imaging Test
      • Spirometry
      • Peak Flow Test
      • Blood Gas Test
      • Lung Volume Test
      • Others
      • By End User
      • Hospitals
      • Physician Offices
      • Clinical Laboratories
      • By Country
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Test Type:
      • Imaging Test
      • Spirometry
      • Peak Flow Test
      • Blood Gas Test
      • Lung Volume Test
      • Others
      • By End User
      • Hospitals
      • Physician Offices
      • Clinical Laboratories
      • By Country
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Test Type:
      • Imaging Test
      • Spirometry
      • Peak Flow Test
      • Blood Gas Test
      • Lung Volume Test
      • Others
      • By End User
      • Hospitals
      • Physician Offices
      • Clinical Laboratories
      • By Country
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • By Test Type:
      • Imaging Test
      • Spirometry
      • Peak Flow Test
      • Blood Gas Test
      • Lung Volume Test
      • Others
      • By End User
      • Hospitals
      • Physician Offices
      • Clinical Laboratories
      • By Country
      • North Africa
      • Central Africa
      • South Africa
  • Company Profiles
    • CareFusion Corporation *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Carestream Health, Inc.
    • COSMED
    • Futuremed America, Inc.
    • GE Healthcare
    • MGC Diagnostics Corporation
    • ndd Medical Technologies, Inc.
    • Nihon Kohden Corporation
    • Perkin Elmer, Inc.
    • Philips Healthcare
    • Quest Diagnostics
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Test Type
    • Market Snippet, By End User
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions
  • Impact of COVID19 on market

4. Global Respiratory Disease Testing Market, By Test Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Imaging Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Spirometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Peak Flow Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Blood Gas Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Lung Volume Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Respiratory Disease Testing Market, By End User, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Physician Offices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Respiratory Disease Testing Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • CareFusion Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Carestream Health, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • COSMED
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Futuremed America, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MGC Diagnostics Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ndd Medical Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Nihon Kohden Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • PerkinElmer, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Philips Healthcare
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Quest Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact